Studies in human lung cancer cells demonstrated that the 3p-siRNA targeting human survivin gene (3p-survivin-siRNA) induced a 3p-dependent type I IFN response and significantly downregulated lung cancer cell proliferation. This evidence concerns the gene BIRC5 and lung carcinoma.